Hindustan Bio Sciences Ltd.
Snapshot View

View in App

Prices View details >>

3.36 -0.16 ▼-4.6%

28 September 2022, 10:55:00 AM
Volume: 38

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website https://www.hindustanbiosciences.in/
Market Cap 3.61 Cr.
Enterprise Value(EV) 5.78 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -0.45 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 30.69 Trailing Twelve Months Ending 2022-06
Book Value / Share 0.74 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.73 Calculated using Price: 3.52
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.03 Cr. 10,250,800 Shares
FaceValue 10
Company Profile
Hindustan Bio Sciences was incorporated in 1991. It is a limited company with a share capital of U.S $2.5 million based in Hyderabad, India. The people at the helm of affairs of the company are associated with pharmaceutical and healthcare sector for over two decades and are having penetrative knowledge of the needs of the sick. Hindustan Biosciences is a new entrant in the field of biopharmaceutical industry for providing quality healthcare for the treatment of life threatening diseases at affordable cost even to the lower income segment of Indian Society.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.55%
1 Week
+4.02%
1 Month
-5.35%
3 Month
-18.25%
6 Month
-30.72%
1 Year
-7.69%
2 Year
+5.00%
5 Year
+546.15%
10 Year
+98.82%

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -7.71 -11.47 -19.21 -35.60 -10.74 -71.30 5.22 3.67 -52.96
Return on Capital Employed (%) -7.32 -10.57 -16.78 -30.17 -8.37 -49.03 2.68 2.40 -23.70
Return on Assets (%) -6.96 -10.03 -16.51 -30.15 -8.42 -47.82 2.37 1.45 -20.83

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 9 8 7 5 4 2 2 2 1 1
Non Curr. Liab. 0 1 1 0 1 1 2 2 1 1
Curr. Liab. 1 1 0 1 1 1 1 2 1 1
Minority Int.
Equity & Liab. 10 10 8 6 6 4 6 6 3 3
Non Curr. Assets 8 8 7 5 5 3 4 3 2 2
Curr. Assets 2 2 1 1 1 0 2 2 1 1
Misc. Exp. not W/O 0 0
Total Assets 10 10 8 6 6 4 6 6 3 3

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 4 2 1 1 1 1 4 2 1 1
Other Income 0 0
Total Income 4 2 1 1 1 1 4 2 1 1
Total Expenditure -5 -3 -2 -1 -1 -3 -3 -2 -2 -1
PBIDT -1 -1 -1 0 0 -2 0 0 -1 0
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0
Exceptional Items -2
PAT -1 -1 -1 -2 0 -2 0 0 -1 0
Adjusted EPS -1 -1 -1 -2 0 -2 0 0 -1 0

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 -1 1 1
Cash Fr. Inv. 0 0 0 0
Cash Fr. Finan. 0 1 0 -1 0 0 2 -1 -1
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19
Public 87.81 87.81 87.81 87.81 87.81 87.81 87.81 87.81 87.81
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 08 Sep 2022
Reg. 34 (1) Annual Report.
Annual Report for 2021-22
Wed, 07 Sep 2022
Reg. 34 (1) Annual Report.
ANNUAL REPORT FOR FY 2021-22
Fri, 29 Jul 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th July 2022
Outcome of the Board Meeting held on 29th July 2022

Technical Scans View Details >>

Tue, 27 Sep 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 215,220.35 915.10 +2.0%
Divi's Laboratories Ltd. 97,697.75 3,687.00 +0.2%
Cipla Ltd. 88,665.27 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. 69,609.45 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. 61,007.11 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. 51,942.91 1,485.20 -3.2%
Max Healthcare Institute Ltd. 40,110.70 409.15 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.33 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.40 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-06 35.70 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.30 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.06 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.85 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 63.58 409.15 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.30 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.84 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-06 4.13 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.44 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.27 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.13 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.24 409.15 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 409.15 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 409.15 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 409.15 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 409.15 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 915.10 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,687.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,099.15 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,243.90 +1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,273.50 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,485.20 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 409.15 -1.1%

FAQ's On Hindustan Bio Sciences Ltd.

What is Hind Bio Science share price?
Can I buy Hind Bio Science shares now?
What is the Market Cap of Hind Bio Science?
What are the key metrics to analyse Hind Bio Science?
What is the 52 Week High and Low of Hind Bio Science?
What is the trend of Hind Bio Science share price?